四黄水蜜在输液性静脉炎中的应用效果及对疼痛的影响

Application effect of Sihuang water honey in infusion phlebitis and its effect on pain

ES评分 0

DOI 10.12208/j. jmnm.202200140
刊名
Journal of Modern Nursing MedicineJPCNS
年,卷(期) 2022, 1(3)
作者
作者单位

广东省梅州市梅县区中医医院 广东梅州 ;

摘要
分析四黄水蜜用于输液性静脉炎的价值。方法 2021 年 1 月-2022 年 4 月本科接诊输液性 静脉炎病人 82 名,随机均分 2 组。试验组用四黄水蜜,对照组行常规治疗。对比 VAS 评分等指标。结果 关 于 VAS 评分,疗程结束之时:试验组的数据(1.01±0.25)分,和对照组(1.69±0.34)分相比更低(P<0.05)。 关于总有效率,试验组的数据 97.56%,和对照组 80.49%相比更高(P<0.05)。关于 sf-36 评分,疗程结束 之时:试验组的数据(89.31±3.46)分,和对照组(82.52±4.01)分相比更高(P<0.05)。关于疗效满意度, 试验组的数据 97.56%,和对照组 78.05%%相比更高(P<0.05)。结论 输液性静脉炎用四黄水蜜,效果显 著,疼痛感减轻也更为迅速,生活质量改善更加明显。
Abstract
Objective to analyze the value of Sihuang water honey in infusion phlebitis. Methods from January 2021 to April 2022, 82 patients with infusion phlebitis were randomly divided into two groups. The experimental group was treated with Sihuang water honey, and the control group was treated with routine therapy. Compare VAS scores and other indicators. Results as for the VAS score, at the end of the course of treatment: the score of the experimental group was (1.01 ± 0.25), which was lower than that of the control group (1.69 ± 0.34) (P < 0.05). As for the total effective rate, the data of the experimental group was 97.56%, which was higher than that of the control group (80.49%) (P < 0.05). As for the SF-36 score, at the end of the course of treatment: the data of the experimental group (89.31 ± 3.46) was higher than that of the control group (82.52 ± 4.01) (P < 0.05). As for efficacy satisfaction, the data of the experimental group was 97.56%, which was higher than that of the control group (78.05%) (P < 0.05). Conclusion the effect of Sihuang water honey on infusion phlebitis is remarkable, the pain is relieved more quickly, and the quality of life is improved more obviously.
关键词
输液性静脉炎;疼痛;四黄水蜜;疗效
KeyWord
infusion phlebitis; Pain; Four yellow water honey; curative effect
基金项目
页码 25-27
  • 参考文献
  • 相关文献
  • 引用本文

王伟平*. 四黄水蜜在输液性静脉炎中的应用效果及对疼痛的影响 [J]. 现代护理医学杂志. 2022; 1; (3). 25 - 27.

  • 文献评论

相关学者

相关机构